Page last updated: 2024-08-17

ethyl methanesulfonate and Animal Mammary Carcinoma

ethyl methanesulfonate has been researched along with Animal Mammary Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gocke, E; Müller, L; Pfister, T1

Other Studies

1 other study(ies) available for ethyl methanesulfonate and Animal Mammary Carcinoma

ArticleYear
EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
    Toxicology letters, 2009, Nov-12, Volume: 190, Issue:3

    Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents, Alkylating; Carcinogenicity Tests; Dose-Response Relationship, Drug; Drug Contamination; Ethyl Methanesulfonate; Female; Genes, Dominant; Genes, Lethal; Germ-Line Mutation; HIV Protease Inhibitors; Humans; Linear Models; Mammary Neoplasms, Animal; Methyl Methanesulfonate; Mice; Mutagenicity Tests; Nelfinavir; No-Observed-Adverse-Effect Level; Pregnancy; Quantitative Structure-Activity Relationship; Rats; Risk Assessment

2009